Search

everythinglearnresearchcommunity

for

Search:↓

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Oxidative stress is linked to mild patchy alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

No cure exists for alopecia areata, and treatments are personalized.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Researchers found four genes that could help diagnose severe alopecia areata early.